148 related articles for article (PubMed ID: 26818874)
1. Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications.
Labiris NR; Dolovich MB
Br J Clin Pharmacol; 2003 Dec; 56(6):588-99. PubMed ID: 14616418
[TBL] [Abstract][Full Text] [Related]
2. Strategies for overcoming the biological barriers associated with the administration of inhaled monoclonal antibodies for lung diseases.
Matera MG; Calzetta L; Rinaldi B; Cazzola M; Rogliani P
Expert Opin Drug Deliv; 2023; 20(8):1085-1095. PubMed ID: 37715502
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary drug delivery devices and nanosystems as potential treatment strategies for acute respiratory distress syndrome (ARDS).
Dhege CT; Kumar P; Choonara YE
Int J Pharm; 2024 May; 657():124182. PubMed ID: 38697584
[TBL] [Abstract][Full Text] [Related]
4. Glucose-sensing pulmonary delivery of human insulin to the systemic circulation of rats.
Karathanasis E; Bhavane R; Annapragada AV
Int J Nanomedicine; 2007; 2(3):501-13. PubMed ID: 18019848
[TBL] [Abstract][Full Text] [Related]
5. Inhaled RNA drugs to treat lung diseases: Disease-related cells and nano-bio interactions.
Zhang M; Lu H; Xie L; Liu X; Cun D; Yang M
Adv Drug Deliv Rev; 2023 Dec; 203():115144. PubMed ID: 37995899
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery.
Shen AM; Minko T
J Control Release; 2020 Oct; 326():222-244. PubMed ID: 32681948
[TBL] [Abstract][Full Text] [Related]
7. Engineering Biomaterial-Drug Conjugates for Local and Sustained Chemotherapeutic Delivery.
Coburn JM; Kaplan DL
Bioconjug Chem; 2015 Jul; 26(7):1212-23. PubMed ID: 25689115
[TBL] [Abstract][Full Text] [Related]
8. Particulate bioaerogels for respiratory drug delivery.
Li HY; Makatsoris C; Forbes B
J Control Release; 2024 Jun; 370():195-209. PubMed ID: 38641021
[TBL] [Abstract][Full Text] [Related]
9. Insights into Inhalation Drug Disposition: The Roles of Pulmonary Drug-Metabolizing Enzymes and Transporters.
Dong L; Zhuang X
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731891
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary Delivery of Biological Drugs.
Liang W; Pan HW; Vllasaliu D; Lam JKW
Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33114726
[TBL] [Abstract][Full Text] [Related]
11. Imaging drug delivery to the lungs: Methods and applications in oncology.
Man F; Tang J; Swedrowska M; Forbes B; T M de Rosales R
Adv Drug Deliv Rev; 2023 Jan; 192():114641. PubMed ID: 36509173
[TBL] [Abstract][Full Text] [Related]
12. A novel therapeutic outlook: Classification, applications and challenges of inhalable micron/nanoparticle drug delivery systems in lung cancer (Review).
Xie L; Xie D; Du Z; Xue S; Wang K; Yu X; Liu X; Peng Q; Fang C
Int J Oncol; 2024 Apr; 64(4):. PubMed ID: 38391039
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary inhalation for disease treatment: Basic research and clinical translations.
Wang B; Wang L; Yang Q; Zhang Y; Qinglai T; Yang X; Xiao Z; Lei L; Li S
Mater Today Bio; 2024 Apr; 25():100966. PubMed ID: 38318475
[TBL] [Abstract][Full Text] [Related]
14. 8
Asia Pac J Clin Oncol; 2023 Dec; 19 Suppl 5():3-11. PubMed ID: 38113340
[No Abstract] [Full Text] [Related]
15. Particle Size Dynamics: Toward a Better Understanding of Electronic Cigarette Aerosol Interactions With the Respiratory System.
Sosnowski TR; Odziomek M
Front Physiol; 2018; 9():853. PubMed ID: 30038580
[TBL] [Abstract][Full Text] [Related]
16. Selected Engineering and Physicochemical Aspects of Systemic Drug Delivery by Inhalation.
Sosnowski TR
Curr Pharm Des; 2016; 22(17):2453-62. PubMed ID: 26818874
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary aerosol delivery and the importance of growth dynamics.
Haddrell AE; Lewis D; Church T; Vehring R; Murnane D; Reid JP
Ther Deliv; 2017 Dec; 8(12):1051-1061. PubMed ID: 29125064
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic Considerations of Inhaled Pharmaceuticals for Systemic Delivery.
Hu X; Yang FF; Liao YH
Curr Pharm Des; 2016; 22(17):2532-48. PubMed ID: 26818873
[TBL] [Abstract][Full Text] [Related]
19. The impact of pulmonary diseases on the fate of inhaled medicines--a review.
Wang YB; Watts AB; Peters JI; Williams RO
Int J Pharm; 2014 Jan; 461(1-2):112-28. PubMed ID: 24291124
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
